These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16342001

  • 1. Inhibition of P-glycoprotein function by several antidepressants may not contribute to clinical efficacy.
    Weber CC, Kressmann S, Ott M, Fricker G, Müller WE.
    Pharmacopsychiatry; 2005 Nov; 38(6):293-300. PubMed ID: 16342001
    [Abstract] [Full Text] [Related]

  • 2. Modulation of P-glycoprotein function by St John's wort extract and its major constituents.
    Weber CC, Kressmann S, Fricker G, Müller WE.
    Pharmacopsychiatry; 2004 Nov; 37(6):292-8. PubMed ID: 15551196
    [Abstract] [Full Text] [Related]

  • 3. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.
    Tiberghien F, Loor F.
    Anticancer Drugs; 1996 Jul; 7(5):568-78. PubMed ID: 8862725
    [Abstract] [Full Text] [Related]

  • 4. Modulation of Pgp function by boswellic acids.
    Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M.
    Planta Med; 2006 May; 72(6):507-13. PubMed ID: 16773534
    [Abstract] [Full Text] [Related]

  • 5. Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro.
    Herr AS, Tsolakidou AF, Yassouridis A, Holsboer F, Rein T.
    Neuroendocrinology; 2003 Jul; 78(1):12-22. PubMed ID: 12869795
    [Abstract] [Full Text] [Related]

  • 6. Compound profiling for P-glycoprotein at the blood-brain barrier using a microplate screening system.
    Bauer B, Miller DS, Fricker G.
    Pharm Res; 2003 Aug; 20(8):1170-6. PubMed ID: 12948014
    [Abstract] [Full Text] [Related]

  • 7. St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.
    Ott M, Huls M, Cornelius MG, Fricker G.
    Pharm Res; 2010 May; 27(5):811-22. PubMed ID: 20229133
    [Abstract] [Full Text] [Related]

  • 8. Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C.
    Noack A, Noack S, Hoffmann A, Maalouf K, Buettner M, Couraud PO, Romero IA, Weksler B, Alms D, Römermann K, Naim HY, Löscher W.
    PLoS One; 2014 May; 9(2):e88154. PubMed ID: 24505408
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells.
    Maines LW, Antonetti DA, Wolpert EB, Smith CD.
    Neuropharmacology; 2005 Oct; 49(5):610-7. PubMed ID: 15961125
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
    Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1302-12. PubMed ID: 18234154
    [Abstract] [Full Text] [Related]

  • 11. Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML.
    Legrand O, Simonin G, Perrot JY, Zittoun R, Marie JP.
    Adv Exp Med Biol; 1999 Mar 15; 457():161-75. PubMed ID: 10500791
    [Abstract] [Full Text] [Related]

  • 12. Similarities and differences in the localization, trafficking, and function of P-glycoprotein in MDR1-EGFP-transduced rat versus human brain capillary endothelial cell lines.
    Gericke B, Borsdorf S, Wienböker I, Noack A, Noack S, Löscher W.
    Fluids Barriers CNS; 2021 Aug 03; 18(1):36. PubMed ID: 34344390
    [Abstract] [Full Text] [Related]

  • 13. Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.
    Tiberghien F, Kurome T, Takesako K, Didier A, Wenandy T, Loor F.
    J Med Chem; 2000 Jun 29; 43(13):2547-56. PubMed ID: 10891114
    [Abstract] [Full Text] [Related]

  • 14. The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice.
    Yau JL, Noble J, Thomas S, Kerwin R, Morgan PE, Lightman S, Seckl JR, Pariante CM.
    Neuropsychopharmacology; 2007 Dec 29; 32(12):2520-9. PubMed ID: 17356567
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F, Tiberghien F, Wenandy T, Didier A, Traber R.
    J Med Chem; 2002 Oct 10; 45(21):4598-612. PubMed ID: 12361387
    [Abstract] [Full Text] [Related]

  • 16. Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1).
    Chufan EE, Kapoor K, Sim HM, Singh S, Talele TT, Durell SR, Ambudkar SV.
    PLoS One; 2013 Oct 10; 8(12):e82463. PubMed ID: 24349290
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of P-glycoprotein by newer antidepressants.
    Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE.
    J Pharmacol Exp Ther; 2003 Apr 10; 305(1):197-204. PubMed ID: 12649369
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy.
    Angelini A, Di Febbo C, Ciofani G, Di Nisio M, Baccante G, Di Ilio C, Cuccurullo F, Porreca E.
    Cancer Biol Ther; 2005 Mar 10; 4(3):313-7. PubMed ID: 15876859
    [Abstract] [Full Text] [Related]

  • 19. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
    Jansson PJ, Yamagishi T, Arvind A, Seebacher N, Gutierrez E, Stacy A, Maleki S, Sharp D, Sahni S, Richardson DR.
    J Biol Chem; 2015 Apr 10; 290(15):9588-603. PubMed ID: 25720491
    [Abstract] [Full Text] [Related]

  • 20. Functional impairment of P-glycoprotein by sodium nitroprusside pretreatment in mouse brain capillary endothelial cells.
    Maeng HJ, Bang YJ, Chung SJ.
    Arch Pharm Res; 2012 Jul 10; 35(7):1215-21. PubMed ID: 22864744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.